Spinal cord stimulation for chronic refractory pain: Long‐term effectiveness and safety data from a multicentre registry

Abstract

Spinal cord stimulation (SCS) is an established therapy for refractory neuropathic pain. To ascertain the balance between treatment benefits and risks, the French National Authority for Health requested a post‐market registry for real‐world evaluation of the long‐term effectiveness and safety of the therapy.